Programmable polypeptide and nucleic acid nanoparticles

US10407469B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10407469-B2
Application numberUS-201715476083-A
CountryUS
Kind codeB2
Filing dateMar 31, 2017
Priority dateApr 1, 2016
Publication dateSep 10, 2019
Grant dateSep 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are polypeptides that self-assemble into nanoparticles upon binding to nucleic acids. The nanoparticles find use, for example in the delivery of the nucleic acids into cells.

First claim

Opening claim text (preview).

The invention claimed is: 1. A polypeptide comprising an assembly domain and a nucleic-acid-binding domain (NABD), wherein the assembly domain comprises an amino acid sequence selected from the group consisting of: SEQ ID NO:2 and SEQ ID NO:12; and wherein upon binding of the NABD to a nucleic acid to form a polypeptide/nucleic acid complex, the assembly domain facilitates self-assembly of the polypeptide/nucleic acid complex into nanoparticles. 2. The polypeptide of claim 1 , wherein the amino acid sequence comprises SEQ ID NO:2. 3. The polypeptide of claim 2 , wherein the amino acid sequence comprises SEQ ID NO:1. 4. The polypeptide of claim 2 , wherein the amino acid sequence comprises SEQ ID NO:5. 5. The polypeptide of claim 1 , wherein the amino acid sequence comprises SEQ ID NO:12. 6. The polypeptide of claim 5 , wherein the amino acid sequence comprises SEQ ID NO:11. 7. The polypeptide of claim 1 , wherein the NABD binds single-stranded (ss) and/or double-stranded DNA and/or RNA. 8. The polypeptide of claim 1 , wherein the NABD and assembly domain are connected by a linker moiety. 9. The polypeptide of claim 1 , further comprising a bioactive domain that enhances one or more characteristics selected from the group consisting of cell internalization, cell-targeting, endosome escape, and nuclear delivery. 10. The polypeptide of claim 9 , wherein the bioactive domain is selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 8, and SEQ ID NO: 10. 11. A carrier nanoparticle comprising: (a) cargo nucleic acids, and (b) polypeptides of claim 1 . 12. The carrier nanoparticle of claim 11 , wherein the cargo nucleic acid is a single stranded or double stranded DNA or RNA. 13. The carrier nanoparticle of claim 11 , wherein binding of the polypeptide to the cargo nucleic acid facilitates self-assembly of the polypeptide/nucleic acid complexes into the carrier nanoparticles. 14. The carrier nanoparticle of claim 11 , wherein the nanoparticle is between 20 and 800 nm in diameter. 15. A method of delivering a cargo nucleic acid into a cell, comprising exposing the cell to a nanoparticle of claim 11 .

Assignees

Inventors

Classifications

  • containing a domain for self-assembly, e.g. a viral coat protein (includes phage display) · CPC title

  • containing a tag for extracellular membrane crossing, e.g. TAT or VP22 · CPC title

  • containing a nuclear localisation signal · CPC title

  • Cationic antimicrobial peptides, e.g. defensins · CPC title

  • Marker; Tag · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10407469B2 cover?
Provided herein are polypeptides that self-assemble into nanoparticles upon binding to nucleic acids. The nanoparticles find use, for example in the delivery of the nucleic acids into cells.
Who is the assignee on this patent?
Univ Northwestern
What technology area does this patent fall under?
Primary CPC classification C07K14/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).